Ketamine: An update on its abuse

Journal of Pharmacy Practice

Volumn 27, Issue 6, 2014, Pages 582-586

  Bokor, Gyula ^a   Anderson, Peter D ^b  

^a Taunton State Hospital   (United States)

^b Forensic Pharmacologist Private Practice   (United States)

Author keywords

drug information; nephrology; psychopharmacology; substance abuse; toxicology

Indexed keywords

KETAMINE;

ABDOMINAL PAIN; ACUTE TOXICITY; AMNESIA; ARTICLE; AUDITORY HALLUCINATION; BLUNTED AFFECT; BLURRED VISION; BREATHING DISORDER; BRONCHUS DISEASE; CEREBROVASCULAR ACCIDENT; CHILL; COLOR VISION DEFECT; CONSCIOUSNESS DISORDER; DELIRIUM; DIZZINESS; DRUG ABUSE; DRUG EFFECT; DYSURIA; EDEMA; EPIGASTRIC PAIN; ERYTHEMA; FIBROSING ALVEOLITIS; GALLBLADDER DISEASE; GASTRITIS; GASTROENTERITIS; GASTROINTESTINAL TOXICITY; HEART DISEASE; HEART PALPITATION; HEMATURIA; HUMAN; HYDRONEPHROSIS; HYPERTENSION; HYPERTHERMIA; IMPAIRED BLADDER EMPTYING; INTESTINE METAPLASIA; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; LACRIMATION DISORDER; MEMORY DISORDER; MENTAL DISEASE; MOTOR DYSFUNCTION; MUSCLE DISEASE; NAUSEA AND VOMITING; NIGHTMARE; NOSE DISEASE; OVERACTIVE BLADDER; PAIN; PARALYSIS; PARANOIA; RESTLESSNESS; SUBSTANCE ABUSE; SWEAT GLAND DISEASE; TACHYCARDIA; TOXICITY; ULCER; URGE INCONTINENCE; URINARY TOXICITY; URINARY TRACT DISEASE; URINARY URGENCY; UROGENITAL TRACT DISEASE; VISUAL HALLUCINATION; ADDICTION; CHEMICALLY INDUCED; GASTROINTESTINAL DISEASE; PSYCHOLOGY;

GASTROINTESTINAL DISEASES; HUMANS; KETAMINE; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS; UROLOGIC DISEASES;

EID: 84910067029     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190014525754     Document Type: Article

References (60)

1. JohnstonLDO'MalleyPMBachmanJG. Monitoring the future: national survey results on drug use 1975-2012. http://www.monitoringthefuture.org. Accessed August 17, 2013.
2. Strayer RJ, Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med. 2008 ; 26 (9). 985-1028
3. Green SM, Sherwin TS. Incidence and severity of recovery agitation after ketamine sedation in young adults. Am J Emerg Med. 2005 ; 23 (2). 142-144
4. Akporehwe NA, Wilkinson PR, Quibell R, Akporehwe KA. Ketamine: a misunderstood analgesic?. BMJ. 2006 ; 332 (7556). 1466
5. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and γ-hydroxybutyrate. Am J Health System Pharm. 2002 ; 59 (11). 1067-1076
6. Anderson PD, O'Donnell JT. Specific forensic applications for pharmacists. J Pharm Pract. 2000 ; 13 (3). 187-193
7. Lim DK. Ketamine associated psychedelic effects and dependence. Singapore Med J. 2003 ; 44 (1). 31-34
8. Phelps LE, Brutsche N, Moral JR, et al. Family history of alcohol dependence and initial antidepressant response to an N-methyl-d-aspartate antagonist. Biol Psychiatry. 2009 ; 65 (2). 181-184
9. Bobo WV, Miller SC. Ketamine as a preferred substance of abuse. Am J Addict. 2002 ; 11 (4). 332-334
10. Drug Enforcement Administration. Ketamine. http://www.justice.gov/dea/concern/ketamine-factsheet.html. Accessed April 26, 2012.
11. Large CH. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?. J Psychopharmacol. 2012 ; 21 (3). 283-301
12. Deakin JW, Lees J, McKie S, et al. Glutamate and the neural basis of the subjective effects of ketamine. Arch Gen Psychiatry. 2008 ; 65 (2). 154-164
13. Britt GC, McCance Katz EF. A brief overview of the clinical pharmacology of "club drugs.". Subst Use Misuse. 2005 ; 40 (9-10). 1189-1201
14. Gable RS. Acute toxic effects of club drugs. J Psychoactive Drugs. 2004 ; 36 (3). 303-313
15. Shram MJ, Sellers Romach MK. Oral ketamine as a positive control in human abuse potential studies. Drug Alcohol Depend. 2011 ; 114 (2-3). 185-193
16. Critchlow DG. A case of ketamine dependence with discontinuation symptoms. Addiction. 2006 ; 101 (8). 1212-1213
17. Meyer MR, Maurer HH. Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. Pharmacogenomics. 2011 ; 12 (2). 215-233
18. Maxwell JC. Party drugs, properties, prevalence, patterns, and problems. Subst Use Misuse. 2005 ; 40 (9-10). 1203-1240
19. Klein M, Kramer F. Rave drugs: pharmacological considerations. AANA J. 2004 ; 72 (1). 61-67
20. Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J. 2010 ; 16 (1). 6-11
21. Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003 ; 69 (1). 23-28
22. Schifano F, Corkery J, Oyefeso A, et al. Trapped in the "K-hole" overview of deaths associated with ketamine misuse in the UK (1993-2006). J Clin Psychopharmacol. 2008 ; 28 (1). 114-116
23. Cheng JY, Chan DT, Mok VK. An epidemiological study of alcohol/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000. Forensic Sci Int. 2005 ; 153 (2-3). 196-201
24. Poon TL, Wong KF, Chan MY, et al. Upper gastrointestinal problems in inhalational ketamine abusers. J Dig Dis. 2010 ; 11 (2). 106-110
25. Wong SW, Lee KF, Wong J, et al. Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J. 2009 ; 15 (1). 53-56
26. Ng SH, Lee HK, Chan YC, et al. Dilated common bile ducts in ketamine abusers. Hong Kong Med J. 2009 ; 15 (2). 157
27. Seto WK, Ng M, Chan P, et al. Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol. 2011 ; 106 (5). 1004-1005
28. Lo RS, Krishnamoorthy R, Freeman JG, Austin AS. Cholestasis and biliary dilation associated with chronic ketamine abuse: a case series. Singapore Med J. 2011 ; 52 (3). e52 - e55
29. Shahani R, Streutker C, Dickson B, Stewart RJ. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology. 2007 ; 69 (5). 810-812
30. Chu PS, Kwok SC, Lam KM, et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med J. 2007 ; 13 (4). 311-313
31. Chen LY, Chen KP, Huang MC. Cystitis associated with chronic ketamine abuse. Psychiatry Clin Neurosci. 2009 ; 63 (4). 591
32. Chen CH, Lee MH, Chen YC, Lin MF. Ketamine-snorting associated cystitis. J Formos Med Assoc. 2011 ; 110 (12). 787-791
33. Cheung RY, Chan SS, Lee JH, et al. Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use. Hong Kong Med J. 2011 ; 17 (4). 267-273
34. Chu PS, Ma WK, Wong SC, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome?. BJU Int. 2008 ; 102 (11). 1616-1622
35. Cottrell A, Warren K, Ayres R, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome?. BJU Int. 2008 ; 102 (9). 1178-1179
36. Mason K, Cottrell AM, Corrigan AG, et al. Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol. 2010 ; 65 (10). 795-800
37. Wang YC, Chen SK, Lin CM. Breaking the drug addiction cycle is not easy in ketamine abusers. Int J Urol. 2010 ; 17 (5). 496-497
38. Hopcroft SA, Cottrell AM, Mason K, et al. Ureteric intestinal metaplasia in association with chronic recreational ketamine abuse. J Clin Pathol. 2011 ; 64 (6). 551-552
39. Tsai TH, Cha TL, Lin CH, et al. Ketamine-associated bladder dysfunction. Int J Urol. 2009 ; 16 (10). 826-829
40. Mak SK, Chan MT, Bower WF, et al. Lower urinary tract changes in young adults using ketamine. J Urol. 2011 ; 186 (2). 610-614
41. Middela S Pearce I. Ketamine-induced vesicopathy: a literature review. Int J Clin Pract. 2011 ; 65 (1). 27-30
42. Corazza O, Schifano F. Ketamine use: Near-death states reported in a sample of 50 misusers. Subst Use Misuse. 2010 ; 45 (6). 916-924
43. Muetzelfeldt L, Kamboj SK, Rees H, et al. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. 2008 ; 95 (3). 219-229
44. Pomarol-Clotet E, Honey GD, Murray GK, et al. Psychological effects of ketamine in healthy volunteers - phonological study. Br J Psychiatry. 2006 ; 189: 173-179
45. Morgan HL, Turner DC, Corlett PR, et al. Exploring the impact of ketamine on the experience of illusory body ownership. Biol Psychiatry. 2011 ; 69 (1). 35-41
46. Uhlhaas PJ, Millard I, Muetzelfedlt L, et al. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later. J Psychopharmacol. 2007 ; 21 (3). 347-352
47. Dickerson D, Pittman B, Ralevski E, et al. Ethanol-like effects of thiopental and ketamine in healthy humans. J Psychopharmacol. 2010 ; 24 (2). 203-211
48. Stone JM, Abel KM, Allin MP, et al. Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation. Pharmacopsychiatry. 2011 ; 44 (1). 33-38
49. Petrakis IL, Limoncelli D, Gueorguieva R, et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry. 2004 ; 161 (10). 1776-1782
50. Daumann J, Heekeren K, Neukirch A, et al. Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2a agonist and NMDA antagonist of psychosis. Psychopharmacology. 2008 ; 200 (4). 573-583
51. Sterling J, McCoy L. Quantifying the psychological effects of ketamine: from euphoria to the k-hole. Subst Use Misuse. 2010 ; 45 (14). 2428-2443
52. Wilkins LK, Girard TA, Cheyne JA. Ketamine as a primary predictor of out-of-body experiences associated with multiple substance use. Conscious Cogn. 2011 ; 20 (3). 943-950
53. Morgan CJ, Rees H, Curran HV. Attentional bias to incentive stimuli in frequent ketamine abusers. Psychol Med. 2008 ; 38 (9). 1331-1340
54. Curran HV, Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction. 2000 ; 95 (4). 575-590
55. Curran HV, Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction. 2001 ; 96 (5). 749-760
56. Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction. 2010 ; 105 (1). 121-133
57. Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition, and psychological wellbeing: a comparison of frequent, infrequent, and ex-users with polydrug and non-using groups. Addiction. 2009 ; 104 (1). 77-87
58. Morgan CJ, Mofeez A, Brandner B, et al. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology. 2004 ; 29 (1). 208-218
59. Morgan CJ, Rossell SL, Pepper F. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Bio Psychiatry. 2006 ; 59 (3). 265-272
60. Morgan CJ, Monaghan L, Curran HV. Beyond the k-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction. 2004 ; 99 (11). 1450-1461